Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of HC-SVT-1001 and HC-SVT-1002 for atrophic long-bone nonunion
2013-000930-37Phase 2Completed
- Sponsor
- Laboratorios Salvat, S.A.
- Start
- Jun 2013
- Modality
- Cell Therapies, Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of HC-SVT-1001 and HC-SVT-1002 in atrophic nonunion of long bones and fracture nonunion (3 arms), sponsored by Laboratorios Salvat, S.A. Primary endpoints: Effectiveness by radiological bone healing and Safety. Started Jun 2013; status: completed.
02
Drugs
HC-SVT-1001HC-SVT-1002
03
Conditions
atrophic nonunion of long bonesfracture nonunion
Beyond the preview
Go deeper on 2013-000930-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000930-37.